Takayasu arteritis

Disease name confirmation: Takayasu’s arteritis (Takayasu’s arteritis) — This is the medically accepted disease name.

1) Disease Description (Causes and Symptoms)

• Cause: The exact cause is unclear, but it is considered a chronic large-vessel vasculitis of the aorta and its primary branches caused by an autoimmune mechanism.
• Pathophysiology: Full-thickness inflammation of the aorta and major branches (including lymphocytic infiltration and giant-cell changes) → thickening and fibrosis of the vessel wall → stenosis, occlusion, and aneurysm formation → risk of tissue ischemia or rupture.
• Main symptoms
  • Typical prodromal phase (active inflammatory phase): Systemic symptoms such as fever, night sweats, loss of appetite, weight loss, fatigue, and joint pain.
  • Chronic phase (ischemic symptoms caused by vascular damage): Weakening or loss of pulses in the arms or legs, a difference in blood pressure between the upper and lower limbs, intermittent claudication, chest pain (when the aorta or coronary arteries are involved), visual impairment, syncope, stroke symptoms (cerebral ischemia), and hypertension when the renal arteries are involved.
• Epidemiology: It occurs predominantly in young women (in their 20s–30s), and a high incidence has been reported in some regions, such as East Asia.

2) Treatment Methods and Precautions

• Medication (standard)
  • First-line: High-dose corticosteroids (e.g., prednisone) to suppress inflammation. When the response is good, symptoms and inflammatory markers improve.
  • If steroid-dependent or refractory, or to minimize steroid-related adverse effects, immunosuppressants may be used in combination: methotrexate, azathioprine, cyclophosphamide, etc.
  • Biologic agents recently used as standard treatment: IL-6 inhibitors (tocilizumab), etc., may be considered in some patients.
• Hemodynamic and cardiovascular management
  • Blood pressure control: Calcium channel blockers, ACE inhibitors, etc. (important when renal artery lesions are present).
  • Consideration of antiplatelet agents (aspirin): For prevention of thrombosis and ischemia (determined according to the individual patient’s risk).
• Vascular intervention/surgery
  • When severe stenosis, ischemia, or complications (such as organ ischemia or critical stenosis) are present, procedures such as percutaneous angioplasty (including stent placement), bypass grafting, or endarterectomy may be performed.
  • Intervention during an inactive phase of inflammation is associated with a lower risk of restenosis.
• Lifestyle management and monitoring
  • Regular clinical examinations (symptoms and comparison of pulses and blood pressure), inflammatory markers (ESR, CRP), and imaging tests (ultrasonography, CT/MR angiography) to monitor disease activity and structural changes.
  • During immunosuppressive treatment, management of adverse effects such as infection risk, osteoporosis, and worsening blood glucose and blood pressure is necessary.
• Precautions (risk of complications and self-management)
  • Increased risk of infection: Seek prompt evaluation if symptoms of infection, such as fever or cough, occur.
  • Osteoporosis and diabetes: With long-term steroid use, bone density testing and calcium and vitamin D supplementation are needed, along with management of blood glucose and blood pressure.
  • If pregnancy is possible or planned: Medications, especially methotrexate and cyclophosphamide, may harm the fetus, so prior consultation is necessary.
  • Long-term follow-up is necessary because restenosis may occur after vascular reconstruction.
• Prognosis: The disease is relapsing, and its course varies among patients. Symptoms often improve with steroids, but chronic vascular damage may be permanent (imaging monitoring is essential).

3) Checklist Before an Outpatient Visit (What to Prepare and Example Questions)

• What to prepare
  • A list of currently taken medications and supplements (including doses and duration of use)
  • Previous test results (bring copies of blood tests, ESR/CRP, chest X-rays, CT/MR/ultrasound, and angiography results if possible)
  • Symptom record: When symptoms began, what symptoms occurred (fever, night sweats, claudication, visual problems, syncope, etc.), and factors that worsen or relieve symptoms
  • Blood pressure records (compare both upper limbs if possible) and observations related to pulse
  • Possibility of or plans for pregnancy, and vaccination history
• Items to tell the doctor first during the outpatient visit (checkpoints)
  • Whether there have been recent changes in weight or appetite
  • New chest pain or neurological symptoms (decreased vision, weakness, speech impairment)
  • Medication adherence and adverse effects (gastrointestinal symptoms, infection, symptoms of osteoporosis, etc.)

4) Examples of General Questions to Ask the Doctor

• What are the expected effects and side effects of this medication?
• What is the plan for tapering the steroids, and what should be checked during tapering?
• How often should I undergo tests, and which tests (blood tests and imaging tests) are needed?
• I am planning a pregnancy. Which medications or treatments are safe?
• How should I respond if an infection is suspected?

5) Examples of Disease-Specific Questions

• Stenosis (or an aneurysm) has been identified on my current imaging. How are the appropriate timing and risks of reconstruction (angioplasty/surgery) assessed?
• If inflammatory activity (ESR/CRP or MRI findings) repeatedly increases, what is the next treatment step (adding an immunosuppressant or using a biologic agent)?

Additional guidance: Regular blood pressure and pulse checks and imaging follow-up are essential for prognosis and treatment decisions. Medical decisions vary according to the individual patient’s condition (inflammatory activity, location and severity of vascular lesions, comorbidities, etc.), so please consult your treating specialist.